Unveil Logo
← Back to all work
Client engagement Healthcare — Population Health, Health Equity, Value-Based Care

Impactability, health-equity, and avoidable-cost analysis at a major US healthcare system

Beyond risk prediction — analyses identifying intervention-amenable patients, subgroup outcome divergence, and avoidable utilization for value-based-care strategy.

Category
Client engagement
Industry
Healthcare — Population Health, Health Equity, Value-Based Care
Role
Direct contractor
Scope
Impactability framing + health-equity / social-determinants analyses + avoidable-utilization and cost analysis on a population-health cohort
Duration
Multi-month limited engagement (alongside the IP-admission risk-modeling workstream)
Capabilities
Impactability Modeling Health-Equity Analysis Social Determinants of Health Avoidable-Utilization Analysis Cost & Value-Based-Care Analytics Subgroup Fairness Diagnostics

At a glance

A major US healthcare system needed analytics that went beyond “who is at risk” to answer the harder question: who is at risk and amenable to intervention, in ways that close — rather than widen — equity gaps, and where the underlying utilization is actually avoidable? UNVEIL was retained as a direct external contractor to deliver this stream of work alongside the population’s predictive risk-modeling effort. Findings were designed to inform the client’s value-based-care contracts, health-equity initiatives, and supportive-housing strategy.

The situation

The client operates in a value-based-care environment where being penalized for unavoidable utilization is bad analytics, and intervening with patients who would not benefit is bad medicine. Three connected questions had to be answered together to allocate care-management resources well:

  1. Impactability — among the highest-risk patients, which ones have plausibly preventable events that an outpatient intervention could change?
  2. Equity — where do outcomes, risk levels, or intervention amenability diverge across subgroups defined by social and demographic factors? Does the program reduce or reproduce those gaps?
  3. Cost / avoidable utilization — which slice of the predicted utilization is genuinely avoidable, and what is its dollar shape under the system’s risk-bearing contracts?

The strategic context spanned population health, health equity, value-based care, financial sustainability, and supportive-housing initiatives — and the analyses had to support all five.

The challenge

These three lenses interlock and contradict each other in interesting ways:

  1. Risk ≠ impactability. A frail patient near end-of-life is high-risk, but their hospitalization may not be preventable in any clinically or ethically meaningful sense. Targeting them for “impactability” interventions wastes resources and can harm care.
  2. Optimizing against avoidable cost can entrench inequity. If the most “impactable” patients in your data are the ones the existing system already serves well, doubling down on them widens gaps. Equity analysis has to be in the loop, not added as an afterthought.
  3. Social determinants are signal, not noise. Housing instability and homelessness are predictors of avoidable utilization in their own right, and targets for upstream intervention. Both framings had to be supported.
  4. Healthcare-grade rigor. Calibration across subgroups, leakage controls, sensitivity to small-n cohorts, and clear documentation of methodological choices — non-negotiable for clinical and contracting use.

Our approach

We worked inside the client’s secure cloud ML environment, using their data and infrastructure standards.

The outcome

What this means for you

If you operate a value-based-care program, a population-health initiative, or any decision-support system where you need to allocate finite intervention resources well, we can:

Want to talk about a similar problem in your population? Contact us.

Ready to talk about your project?

We respond within one business day.

← See all work